INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 411m ago
House PTR11m ago
SEC 13F11m ago
Robinhood Chain11m ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K

Form 4 transactions

65,929 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
24
TK
Tsang Chi KeungDirector, Chief Executive Officer
BMNRBITMINE IMMERSION TECHNOLOGIES, INC.
Grant or award
A—
30.2K sh
Apr 2, 2026
Page 118 of 1649
← PrevNext →
Oct 26, 2026
traded Apr 2, 2026
+207d
SEC Form 4

Evidence

24
SS
Staben StevenChief Scientific Officer, 10% Owner
LYCALycia Therapeutics, Inc.
Grant or award
A—
110.9K sh
Aug 11, 2026Oct 26, 2026
traded Aug 11, 2026
+76dSEC Form 4

Evidence

24
TS
Touami SofiaChief Business Officer
LYCALycia Therapeutics, Inc.
Grant or award
A—
68.8K sh
Aug 11, 2026Oct 26, 2026
traded Aug 11, 2026
+76dSEC Form 4

Evidence

24
WL
Wilson Kenneth L.GEVP Chief Wealth Officer
CFRCULLEN/FROST BANKERS, INC.
Tax withholding
F$193K
1,230 sh
Oct 24, 2026Oct 26, 2026
traded Oct 24, 2026
+2dSEC Form 4

Evidence

24
FL
Fischer LaurentDirector
LYCALycia Therapeutics, Inc.
Grant or award
A—
13.3K sh
Aug 11, 2026Oct 26, 2026
traded Aug 11, 2026
+76dSEC Form 4

Evidence

24
BA
Bachrodt AmyChief Financial Officer, 10% Owner
LYCALycia Therapeutics, Inc.
Grant or award
A—
399.7K sh
Aug 11, 2026Oct 26, 2026
traded Aug 11, 2026
+76dSEC Form 4

Evidence

24
AT
Archer TimothyPresident and CEO
LRCXLAM RESEARCH CORP
Open-market sale · 10b5-1 plan
SELL$7.13M
31.4K sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC Form 4

Evidence

24
TW
Trombley Aetna WunDirector, President and CEO, 10% Owner
LYCALycia Therapeutics, Inc.
Grant or award
A—
443.6K sh
Aug 11, 2026Oct 26, 2026
traded Aug 11, 2026
+76dSEC Form 4

Evidence

24
TK
Tsang Chi KeungDirector, Chief Executive Officer
BMNRBITMINE IMMERSION TECHNOLOGIES, INC.
Option exercise
M—
142 sh
Jul 23, 2026Oct 26, 2026
traded Jul 23, 2026
+95dSEC Form 4

Evidence

24
TK
Tsang Chi KeungDirector, Chief Executive Officer
BMNRBITMINE IMMERSION TECHNOLOGIES, INC.
Grant or award
A—
15.1K sh
Apr 2, 2026Oct 26, 2026
traded Apr 2, 2026
+207dSEC Form 4

Evidence

24
HJ
Henderson JaneDirector
LYCALycia Therapeutics, Inc.
Grant or award
A—
57.7K sh
Aug 11, 2026Oct 26, 2026
traded Aug 11, 2026
+76dSEC Form 4

Evidence

24
LH
Lee Chin HyokChief Medical Officer, 10% Owner
LYCALycia Therapeutics, Inc.
Grant or award
A—
73.2K sh
Aug 11, 2026Oct 26, 2026
traded Aug 11, 2026
+76dSEC Form 4

Evidence

24
TK
Tsang Chi KeungDirector, Chief Executive Officer
BMNRBITMINE IMMERSION TECHNOLOGIES, INC.
Grant or award
A—
4,186 sh
Apr 7, 2026Oct 26, 2026
traded Apr 7, 2026
+202dSEC Form 4

Evidence

24
RE
Reuter EmilyCHIEF FINANCIAL OFFICER
CARTMaplebear Inc.
Open-market sale · 10b5-1 plan
SELL$2.75M
50.0K sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC Form 4

Evidence

23
PA
Perriman Damien AlanChief Commercial Officer
EXOZEXOZYMES INC.
Option exercise
M—
3,922 sh
Oct 9, 2026Oct 26, 2026
traded Oct 9, 2026
+17dSEC Form 4

Evidence

23
TK
Tsang Chi KeungDirector, Chief Executive Officer
BMNRBITMINE IMMERSION TECHNOLOGIES, INC.
Tax withholding
F$34K
1,294 sh
Sep 30, 2026Oct 26, 2026
traded Sep 30, 2026
+26dSEC Form 4

Evidence

23
PA
Perriman Damien AlanChief Commercial Officer
EXOZEXOZYMES INC.
Option exercise
M—
3,922 sh
Oct 9, 2026Oct 26, 2026
traded Oct 9, 2026
+17dSEC Form 4

Evidence

22
VV
Vitale Robert VDirector, EXECUTIVE CHAIRMAN
POSTPost Holdings, Inc.
Tax withholding
F$4.09M
52.4K sh
Oct 22, 2026Oct 26, 2026
traded Oct 22, 2026
+4dSEC Form 4

Evidence

22
RC
Rogers CampbellChief Medical Officer
HTFLHeartflow, Inc.
Open-market sale · 10b5-1 plan
SELL$1.32M
23.9K sh
Oct 22, 2026Oct 26, 2026
traded Oct 22, 2026
+4dSEC Form 4

Evidence

22
CN
Catoggio NicolasPRES & CEO
POSTPost Holdings, Inc.
Tax withholding
F$1.45M
18.5K sh
Oct 22, 2026Oct 26, 2026
traded Oct 22, 2026
+4dSEC Form 4

Evidence

22
WW
Westphal Mark WPRES., FOODSERVICE
POSTPost Holdings, Inc.
Tax withholding
F$1.37M
17.5K sh
Oct 22, 2026Oct 26, 2026
traded Oct 22, 2026
+4dSEC Form 4

Evidence

22
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$1.10M
22.7K sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC Form 4

Evidence

22
GA
Grimme ArneDirector
NBISNebius Group N.V.
Open-market purchase · 10b5-1 plan
BUY$58K
357 sh
Oct 22, 2026Oct 26, 2026
traded Oct 22, 2026
+4dSEC Form 4

Evidence

22
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$2.25M
46.2K sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC Form 4

Evidence

21
GD
Geddes DanGEVP & Chief Financial Officer
CFRCULLEN/FROST BANKERS, INC.
Option exercise
M—
2,004 sh
Oct 24, 2026Oct 26, 2026
traded Oct 24, 2026
+2dSEC Form 4

Evidence

21
TK
Tsang Chi KeungDirector, Chief Executive Officer
BMNRBITMINE IMMERSION TECHNOLOGIES, INC.
Option exercise
M—
141 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC Form 4

Evidence

21
KP
Khales PaymanDirector, President & CEO
ITGRInteger Holdings Corp
Option exercise
M—
2,514 sh
Oct 24, 2026Oct 26, 2026
traded Oct 24, 2026
+2dSEC Form 4

Evidence

21
DS
Dadyar SaraSVP, Global Head HR
AYIACUITY INC. (DE)
Grant or award
A—
1,388 sh
Oct 22, 2026Oct 26, 2026
traded Oct 22, 2026
+4dSEC Form 4

Evidence

21
GJ
Gray Diedre JEVP, GC & CAO, SECY
POSTPost Holdings, Inc.
Grant or award
A—
42.3K sh
Oct 22, 2026Oct 26, 2026
traded Oct 22, 2026
+4dSEC Form 4

Evidence

21
BR
Bradshaw RichardEVP, Chief Banking Officer
UCBUNITED COMMUNITY BANKS INC
Open-market sale
SELL$50K
1,339 sh
Oct 26, 2026Oct 26, 2026
traded Oct 26, 2026
+0dSEC Form 4

Evidence

21
SM
Sharett Anthony M.President
CASHPATHWARD FINANCIAL, INC.
Disposition to issuer
D—
9,113 sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC Form 4

Evidence

21
HB
Henson Matthew BradleyChief Accounting Officer
CFRCULLEN/FROST BANKERS, INC.
Option exercise
M—
707 sh
Oct 24, 2026Oct 26, 2026
traded Oct 24, 2026
+2dSEC Form 4

Evidence

21
MP
McCarthy Eileen PGeneral Counsel Corp Sec
JBLUJETBLUE AIRWAYS CORP
Option exercise
M—
27.8K sh
Oct 22, 2026Oct 26, 2026
traded Oct 22, 2026
+4dSEC Form 4

Evidence

21
LE
Lyons EmerChief Accounting Officer
ICLRICON PLC
Option exercise
M—
510 sh
Oct 22, 2026Oct 26, 2026
traded Oct 22, 2026
+4dSEC Form 4

Evidence

21
ZA
Zadoks Jeff ADirector
POSTPost Holdings, Inc.
Grant or award
A—
40.7K sh
Oct 22, 2026Oct 26, 2026
traded Oct 22, 2026
+4dSEC Form 4

Evidence

21
KL
Kao LeeCo-Founder & General Manager, 10% Owner
SCTHSecuretech Innovations, Inc.
Grant or award
A—
1.70M sh
Oct 22, 2026Oct 26, 2026
traded Oct 22, 2026
+4dSEC Form 4

Evidence

21
MP
McCarthy Eileen PGeneral Counsel Corp Sec
JBLUJETBLUE AIRWAYS CORP
Option exercise
M—
27.8K sh
Oct 22, 2026Oct 26, 2026
traded Oct 22, 2026
+4dSEC Form 4

Evidence

21
BR
Bradshaw RichardEVP, Chief Banking Officer
UCBUNITED COMMUNITY BANKS INC
Open-market sale
SELL$222
6 sh
Oct 26, 2026Oct 26, 2026
traded Oct 26, 2026
+0dSEC Form 4

Evidence

21
WL
Wilson Kenneth L.GEVP Chief Wealth Officer
CFRCULLEN/FROST BANKERS, INC.
Option exercise
M—
3,125 sh
Oct 24, 2026Oct 26, 2026
traded Oct 24, 2026
+2dSEC Form 4

Evidence

21
SS
Sitra J ScottDirector, President & CEO, 10% Owner
SCTHSecuretech Innovations, Inc.
Grant or award
A—
3.50M sh
Oct 22, 2026Oct 26, 2026
traded Oct 22, 2026
+4dSEC Form 4

Evidence